An Online Partnering and Valuation Platform for Life Sciences Industry
+1 973-460-2680

Latest News

Amgen's Otezla notches win in genital psoriasis, snagging possible edge against forthcoming BMS rival fkansteiner Thu, 12/02/2021 - 10:02
Aspen Pharmacare, pursuing J&J vaccine license, aims to shore up local capacity and quash shot inequality in Africa fkansteiner Thu, 12/02/2021 - 07:59
Fujifilm socks $530M into U.K. vaccine, gene therapy and microbial production, creating 350 jobs fkansteiner Wed, 12/01/2021 - 16:45
Sanofi aims to double vaccine sales by 2030, citing RSV and flu market expansion as key drivers esagonowsky Wed, 12/01/2021 - 13:51
Moderna loses bid to invalidate vaccine delivery patents, teeing up potential infringement lawsuit fkansteiner Wed, 12/01/2021 - 12:42
Amgen stalls Samsung's Enbrel biosim until 2029 in 2nd patent win of the year fkansteiner Wed, 12/01/2021 - 08:40
Biogen takes another blow as appeal for Tecfidera patent revival falls short fkansteiner Tue, 11/30/2021 - 15:13
GSK's ViiV looks to future of injectable HIV treatment as long-acting PrEP decision looms fkansteiner Tue, 11/30/2021 - 11:10
Aspen closes in on Africa license for Johnson & Johnson's COVID-19 vaccine fkansteiner Tue, 11/30/2021 - 09:05
COVID-19 tracker: GSK-Vir win mAb antiviral UK nod, AstraZeneca drops booster testing in US elucas Mon, 11/29/2021 - 15:31
Pfizer boosts Paxlovid manufacturing capacity as Merck's rival COVID pill hits surprise efficacy setback aliu Mon, 11/29/2021 - 11:38
Amgen asks Supreme Court to take up its high-profile PCSK9 patent case against Sanofi and Regeneron fkansteiner Mon, 11/29/2021 - 11:15
Novo Nordisk, Sanofi and Eli Lilly cut insulin prices and lose share in China's latest cost squeeze aliu Mon, 11/29/2021 - 10:27
Former Insys execs ordered to pay $48.3M in restitution in Subsys opioid trial fkansteiner Mon, 11/29/2021 - 09:15
Acadia gives voice to personal stories about Parkinson's psychosis in new bilingual campaign nmissakian Wed, 11/24/2021 - 15:38
Pfizer says former employee stole trade secrets on megablockbuster COVID-19 vaccine esagonowsky Wed, 11/24/2021 - 11:38
Bushu expects to double the volume of Amgen drugs it makes under new Asia CMO pact fkansteiner Wed, 11/24/2021 - 10:38
Sun Pharma loses bid to drop Ranbaxy antitrust case; jury trail set for January kdunleavy Wed, 11/24/2021 - 10:25
After Biden admin failed to submit FDA chief paperwork on time, hopes for a speedy confirmation vote likely dashed: report fkansteiner Wed, 11/24/2021 - 09:04
Sanofi's Icy Hot teams up with Shaquille O'Neal Foundation to help people rise up from pain—this time, mental pain sharon.coey Wed, 11/24/2021 - 07:12
FDA, working to tackle pandemic inspection backlog, struggles with foreign oversight and site visits for new drugs fkansteiner Tue, 11/23/2021 - 13:14
Aadi clinches first FDA nod for ultrarare sarcoma drug Fyarro fkansteiner Tue, 11/23/2021 - 09:14
GlaxoSmithKline takes aim at sick pay access inequities with microgrant program and new campaign nmissakian Mon, 11/22/2021 - 15:48
ARIA side effects surface in 40% of patients on Biogen's Alzheimer's drug Aduhelm: JAMA fkansteiner Mon, 11/22/2021 - 15:12
Sagent Pharmaceuticals recalls injectable seizure med thanks to familiar packaging glitch fkansteiner Mon, 11/22/2021 - 13:34
Alpha challenger: Novartis pays UCB $150M to join Roche, AstraZeneca in Parkinson's race ntaylor Thu, 12/02/2021 - 07:48
GlaxoSmithKline, University of Oxford join forces in $40M digital deep dive into neuro badams Thu, 12/02/2021 - 05:40
Tune Therapeutics' epigenetic platform resonates with investors as it snags $40M in financing klahucik Wed, 12/01/2021 - 12:58
Aclaris' experimental rheumatoid arthritis drug bolsters chemo in pancreatic cancer models arlene.weintraub Wed, 12/01/2021 - 10:54
Astellas becomes latest Dyno gene therapy partner with $1.6B biobucks pact to join Roche, Novartis, Sarepta klahucik Wed, 12/01/2021 - 09:58
Vertex once again talks up a tiny trial with positive read-throughs, this time for a genetically driven approach to kidney disease badams Wed, 12/01/2021 - 08:08
J&J cell therapy head exits to take up post at fledgling biotech ntaylor Wed, 12/01/2021 - 07:43
Apollo's mission to extend human health span gets $180M boost, giving VC fund a launchpad for age-related disease biotechs ntaylor Wed, 12/01/2021 - 04:50
Britain led the way in COVID trials, but overall clinical study activity still lags: report badams Wed, 12/01/2021 - 04:44
Sanofi snaps up Origimm for early-phase acne vaccine, opening new front in mRNA strategy ntaylor Wed, 12/01/2021 - 02:16
Mei, with Bayer and Gilead in its sights, posts pivotal data on blood cancer prospect ntaylor Tue, 11/30/2021 - 08:54
GlaxoSmithKline poaches Pfizer vax leader Dormitzer after hemorrhaging vaccine R&D talent badams Tue, 11/30/2021 - 08:47
ImmunoGen lines up FDA filing as antibody-drug conjugate shrinks tumors in pivotal trial ntaylor Tue, 11/30/2021 - 07:52
Chinook launches a new biotech with major VCs in China to double down on kidney disease R&D badams Tue, 11/30/2021 - 03:45
RAGE against diabetes complications: Novel drug tamps down tissue damage in mice arlene.weintraub Mon, 11/29/2021 - 12:45
Could common antihistamines be the key to boosting immuno-oncology treatments? arlene.weintraub Mon, 11/29/2021 - 09:23
Turnstone teams up with Moffitt to race TIL cell therapies into the clinic ntaylor Mon, 11/29/2021 - 08:08
Is molnupiravir a turkey? Merck slips out drop in efficacy of COVID-19 antiviral over Thanksgiving period ntaylor Mon, 11/29/2021 - 06:19
Next-gen CAR player Quell Therapeutics drives into the fast lane with major $156M round badams Mon, 11/29/2021 - 04:49
FDA halts phase 1b Kura Oncology trial in acute myeloid leukemia following patient death klahucik Wed, 11/24/2021 - 08:47
Chasing Regeneron, Pfizer posts data on $250M cardiovascular bet ntaylor Wed, 11/24/2021 - 08:23
Kymera's first-in-class protein degrader shows potential to boost cancer immunotherapy aliu Wed, 11/24/2021 - 07:10
Acorda CMO hits the exit, landing Pharnext job with oversight of phase 3 neurological disorder trial ntaylor Wed, 11/24/2021 - 05:52
Rafael resets after phase 3 flop, parting ways with 5 execs and reinstating telecom tycoon as CEO ntaylor Tue, 11/23/2021 - 08:03
AstraZeneca, after years of delays and spiraling costs, opens Cambridge R&D site. Will the bet pay off? ntaylor Tue, 11/23/2021 - 05:06

Home